<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Toxic Dolls | Topp Greenwood | Activity</title>
	<link>https://toxicdolls.com/members/neededge68/activity/</link>
	<atom:link href="https://toxicdolls.com/members/neededge68/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Topp Greenwood.</description>
	<lastBuildDate>Sat, 02 May 2026 12:18:40 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">8bd55911811d115ce233ff993d113def</guid>
				<title>Topp Greenwood posted an update: Information Technology (IT) and specialized systems could [&#133;]</title>
				<link>https://toxicdolls.com/activity-2/p/4682/</link>
				<pubDate>Fri, 20 Jun 2025 08:37:32 +0000</pubDate>

									<content:encoded><![CDATA[<p>Information Technology (IT) and specialized systems could have a prominent role towards the support of drug safety processes, both in the clinical context but also beyond that. PVClinical project aims to build an IT platform, enabling the investigation of potential Adverse Drug Reactions (ADRs). In this paper, we outline the utilization of&hellip;<span class="activity-read-more" id="activity-read-more-4682"><a href="https://toxicdolls.com/activity-2/p/4682/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">0fb0673ff6c3e5dc5c619eea37b98563</guid>
				<title>Topp Greenwood became a registered member</title>
				<link>https://toxicdolls.com/activity-2/p/4602/</link>
				<pubDate>Fri, 20 Jun 2025 08:05:23 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>